Filing Flows

Filing Flows › Bio Green Med Solution (BGMS) › Q1 2026 › vs Q4 2025

Bio Green Med Solution (BGMS) Q1 2026 vs Q4 2025 (quarter over quarter)

Bio Green Med Solution's revenue rose $77K (+12%) from $666K in Q4 2025 to $743K in Q1 2026.

Bio Green Med Solution, Q1 2026: revenue $743K, operating margin -33.1%, net loss $197K, operating cash flow −$278K. The chart draws each line against Q4 2025, the increases inside each band.

Bio Green Med Solution: what changed, Q1 2026 vs Q4 2025Bio Green Med Solution: what changed, Q1 2026 vs Q4 2025General & admin−$861KOperating costs−$759KCosts & expenses−$734KShare-based compensation−$654KNet loss−$414KNet loss absorbed−$414KOperating cash sources−$412KOther income, net−$397KCash used in operations$245KOther operating costs$102K

Every line

LineQ1 2026Q4 2025Change%
Revenue$743K$666K$77K+12%
Other income, net$79K$476K−$397K-83%
Net loss$197K$611K−$414K-68%
Costs & expenses$1.0M$1.8M−$734K-42%
Operating costs$989K$1.7M−$759K-43%
Income tax$30K$5K$25K+500%
General & admin$389K$1.2M−$861K-69%
Other operating costs$600K$498K$102K+20%
Operating cash sources$280K$692K−$412K-60%
Depreciation$1K$4K−$3K-75%
Share-based compensation$1K$655K−$654K-100%
Cash used in operations$278K$33K$245K+742%
Net loss absorbed$197K$611K−$414K-68%
Working capital & other$83K$81K$2K+2%

Questions

How much did Bio Green Med Solution's revenue grow quarter over quarter in Q1 2026?

Bio Green Med Solution's revenue rose $77K (+12%) from $666K in Q4 2025 to $743K in Q1 2026.

Q1 2026 results → · Compare in the interactive Sankey →